Enjaymo (sutimlimab-jome)

Adult Dosing .

Dosage forms:  INJ

Special Note

[drug name clarification]

Info: nonproprietary name = sutimlimab-jome

hemolysis, cold agglutinin disease-associated

[39-74.9 kg]

Dose: 6500 mg IV qwk x2 doses, then 6500 mg IV q2wk; Info: if >17 days since last dose, restart qwk x2 doses

[>75 kg]

Dose: 7500 mg IV qwk x2 doses, then 7500 mg IV q2wk; Info: if >17 days since last dose, restart qwk x2 doses

renal dosing

[see below]

CrCl >30: no adjustment; CrCl <30: not defined

HD/PD: not defined

hepatic dosing

[not defined]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.